A patient calls five days after delivery. She says she’s bleeding and wants to know if it’s normal.

“How much are you bleeding?” I ask.

“A lot, I think?”

“Are you soaking through a pad in an hour? How many pads are you using in a day?”

Long pause. “I haven’t really been counting.”

Postpartum is chaos. You’re exhausted, overwhelmed, and completely focused on keeping a tiny human alive. Your own body becomes an afterthought. But the weeks after birth are a vulnerable time. Things can go wrong—sometimes quickly. Knowing your numbers helps you tell the difference between normal recovery and something that needs attention.

Interactive Postpartum Warning Signs Guide

Your Body Just Did Something Enormous. It Needs Monitoring Too.

Pregnancy gets nine months of careful tracking. Prenatal visits, ultrasounds, blood tests, kick counts. Then the baby comes out and suddenly all that attention shifts to the newborn. You’re handed a baby and sent home with instructions for infant care—but often very little guidance about what to expect for yourself.

Here’s the truth: your body doesn’t reset the moment you deliver. Blood pressure issues can develop or worsen after birth. Bleeding can become dangerous. Infections can set in. Mood disorders can emerge. These aren’t rare complications—they’re common enough that every postpartum person should know the warning signs.

The problem is that postpartum symptoms are easy to dismiss. You’re supposed to be tired. You’re supposed to be uncomfortable. You’re supposed to bleed. So how do you know when “supposed to” becomes “something’s wrong”?

Numbers help.

The rest of this post is for paid subscribers.

Read more

A patient tells me she’s been trying to get pregnant “for a while” and it’s not working.

“How long have you been trying?” I ask.

“I don’t know, maybe six months? Maybe longer?”

“And when do you typically ovulate?”

Blank stare. “I’m not sure. We just... try a lot.”

I hear this constantly. Couples are told to “relax and let it happen,” so they don’t track anything. Then months pass, frustration builds, and when they finally seek help, they can’t answer basic questions about their cycles. We’re starting from scratch when we could have been months ahead.

Your Body Gives You a Fertility Window. Numbers Help You Find It.

Here’s the reality: you can only get pregnant during a narrow window each cycle. An egg lives 12 to 24 hours after ovulation. Sperm can survive up to five days in the reproductive tract. That gives you roughly six days per cycle when pregnancy is possible—the five days before ovulation and the day of ovulation itself.

Miss that window, and it doesn’t matter how often you have sex the rest of the month. Hit it, and your chances go up dramatically.

The problem is that ovulation doesn’t happen on the same day for everyone, and it doesn’t always happen on the same day for you. Tracking helps you find your window instead of guessing at it

The rest of this post is for paid subscribers.

Read more

I decided to find out.

I took two real clinical scenarios and asked them across tiers of ChatGPT:

OpenAI’s public pricing page lists the current plan categories: Free, Go, Plus, Pro, Business, and Enterprise. Current U.S. list prices, in short:

• Free: $0/month.

• Go: about $8/month, availability and price vary by country.

• Plus: $20/month.

• Pro: $200/month.

• Business: $25/user/month billed annually, or $30/user/month billed monthly, minimum 2 users. OpenAI’s business pricing page lists the annual plan and notes the monthly billing price.

• Enterprise: custom pricing, contact sales.

Prompt: “What is the management of a preeclamptic patient at 29 weeks””

Free-tier style answer:
At 29 weeks, preeclampsia is managed with close maternal and fetal monitoring. The patient may need hospital admission, blood pressure control, lab testing, fetal surveillance, corticosteroids for fetal lung maturity, and magnesium sulfate if severe features are present. Delivery is considered if the mother or fetus becomes unstable.

Prompt: “How should I counsel a patient with prior preterm birth at 27 weeks now a cervix of 15 mm at 18 weeks?”

I would assume this means a singleton pregnancy, an asymptomatic patient, a prior spontaneous preterm birth at 27 weeks, and a transvaginal cervical length of 15 mm at 18 weeks. If the prior 27-week birth was medically indicated, PPROM, twins, fetal anomaly, or infection-related, counseling would change.

Free-tier style answer:
This patient is at high risk for another preterm birth. She should be referred to maternal-fetal medicine. Management may include cervical cerclage, vaginal progesterone, repeat cervical length monitoring, and counseling about warning signs such as contractions, bleeding, leaking fluid, or pelvic pressure. She should be followed closely.

Below is for paid subscribers only. Find the answers based on the tiers. The rest of this post is for paid subscribers.

Read more

A low ferritin level during pregnancy is not a laboratory curiosity. It is a clinical problem with a trajectory. Ferritin measures stored iron. When stores fall, the body begins borrowing from itself: first from the liver, then from muscle, then from red cell precursors.

By the time hemoglobin drops below 11 g/dL, iron deficiency has already been present for weeks or months. Waiting for that threshold to treat is not watchful waiting. It is delayed care.

The question is no longer whether iron deficiency in pregnancy matters.

It does.

The questions are who qualifies for IV iron, when, and why access remains so difficult even when the clinical picture is unambiguous.

What Iron Deficiency Actually Does in Pregnancy

Iron requirements increase roughly six-fold during pregnancy, from approximately 1 mg per day outside of pregnancy to 6 mg per day in the third trimester (1). Oral supplementation addresses part of this demand but is limited by absorption, tolerance, and compliance. The gut absorbs a fraction of what is swallowed, and side effects from oral iron, including nausea, constipation, and abdominal pain, lead many women to take it inconsistently or stop entirely.

Iron deficiency anemia affects an estimated 38% of pregnant women worldwide (2).

In the United States, Black and low-income women are disproportionately affected, a disparity driven by baseline dietary access and unequal access to prenatal care (3).

But the burden extends well beyond official anemia statistics. Iron depletion without anemia, meaning low ferritin with a still-normal hemoglobin, is not captured in those numbers.

The downstream consequences are documented.

Maternal anemia increases the risk of postpartum hemorrhage through impaired uterine contractility (4). Low postpartum iron stores are associated with a two- to four-fold increase in the odds of postpartum depression across multiple studies (5). Postpartum anemia has also been linked to impaired cognition, early cessation of breastfeeding, and fatigue severe enough to interfere with infant care (6). Neonatal iron stores depend on maternal iron status in the third trimester, when the majority of fetal iron transfer occurs (1). A depleted mother is more likely to deliver a neonate with depleted stores.

These are not speculative associations. They are consistent findings across observational data, and they argue for treating iron deficiency before hemoglobin collapses, not after.

The Evidence for IV Iron

ACOG Practice Bulletin Number 233 (2021) defines anemia in pregnancy as a hemoglobin below 11 g/dL in the first and third trimesters and below 10.5 g/dL in the second trimester (7). It recommends oral iron as first-line treatment and acknowledges IV iron as safe and effective for patients who do not respond to oral therapy, cannot tolerate it, or require rapid iron repletion. That threshold requirement, oral iron failure, is where the access problem begins.

Subscribe now

A 2024 meta-analysis including six studies and 3,842 participants found that IV iron produced significantly higher hemoglobin compared to oral iron, with a pooled mean difference of 1.21 g/dL (95% CI 0.83 to 1.59), and was more than twice as likely to correct anemia (OR 2.47; 95% CI 1.69 to 3.61) (8). The efficacy advantage of IV iron over oral iron is not a fringe finding. It is replicated across randomized controlled trials and meta-analyses.

The safety concern most often cited is hypersensitivity. That concern is outdated in its severity framing. Older dextran-based formulations carried real anaphylaxis risk. Modern formulations do not. For ferric carboxymaltose, the adjusted anaphylaxis rate in Medicare data is 0.8 per 10,000 first doses (9). Serious reactions are rare, and they occur in settings already equipped to manage them. A 30-minute infusion with 30 minutes of monitoring does not require intensive care capacity. It requires a chair, a line, and a nurse familiar with the protocol.

Ferric carboxymaltose permits single-dose administration of up to 1,000 mg in a 15-minute infusion with a well-characterized safety profile across more than 8,000 subjects in clinical studies (10). The argument that IV iron is too risky for routine use in pregnancy is not supported by the pharmacovigilance data on modern formulations.

The rest of this post is for paid subscribers.

Read more

Tennessee has a maternal mortality rate of 41 per 100,000 live births.

California’s is 10.

Mississippi’s neonatal mortality rate is 5.3 per 1,000 live births.

Vermont’s is 2.1.

These are not random numbers. Two datasets, drawn from CDC/NCHS vital statistics and America’s Health Rankings analyses of CDC WONDER, show the same pattern: states with higher Republican presidential vote shares in 2020 have substantially worse maternal and neonatal mortality.

The maternal mortality correlation coefficient is 0.57. For neonatal mortality, it is 0.43. Both charts note explicitly that these are ecological associations, not causal ones. That disclaimer matters, and I will return to it. But a correlation coefficient of 0.57 is not noise. It is a signal that demands explanation.

Subscribe now

What the Data Actually Show

The maternal mortality scatter plot covers 2018 to 2022, using CDC/NCHS state-level rates. The neonatal mortality plot covers 2022 to 2023 from America’s Health Rankings. Both use 2020 presidential vote share as the X-axis. In both charts, the fitted regression line runs upward left to right: states with lower Republican vote shares cluster toward the bottom, states with higher vote shares cluster toward the top.

The outliers are instructive. Utah votes heavily Republican and has a maternal mortality rate around 15.5 per 100,000 -- well below the trend line.

West Virginia sits high-Trump and relatively moderate on maternal mortality compared to Mississippi or Tennessee.

Delaware, a blue state, has a neonatal mortality rate near 4.9. No correlation in population-level data is clean.

What matters is the pattern across dozens of states, not any single data point.

The pattern is real. In states that voted more than 60% for Trump in 2020, maternal mortality consistently runs above 37 per 100,000 live births. In states below 35% Trump share, it runs closer to 10 to 13. That is a three-to-four-fold difference in the rate at which women die from pregnancy-related causes, depending on which state they live in.

Correlation Is Not Causation -- But the Mechanisms Are Not a Mystery

This matters: voting Republican does not cause maternal death. The ecological fallacy reminds us that state-level associations do not translate to individual-level causation. A state’s average vote share and its average mortality rate are population-level statistics, and we cannot infer that any individual voter is at elevated risk because of her politics.

Subscribe now

What we can ask is why these two variables track together at the state level. And here the answer is not mysterious. It is healthcare policy. The states that vote most heavily Republican are, with notable exceptions, the same states that rejected Medicaid expansion under the Affordable Care Act, that have the fewest OB/GYN physicians per capita, that have enacted the most restrictive abortion laws (which have well-documented downstream effects on obstetric care capacity and physician recruitment), and that have the highest proportions of rural counties without a labor and delivery unit.

Medicaid finances 41% of all births in the United States nationwide. In Louisiana, Mississippi, New Mexico, and Oklahoma, more than half of all births are Medicaid-financed. These states are also among the highest on both mortality curves. Medicaid is not a peripheral program for maternal health. It is the program. Remove it or restrict it, and you are removing the financial infrastructure that keeps maternity care functioning in the communities where it is most needed.

Share

There is also the abortion care dimension, which clinicians are not permitted to ignore. Since 2022, multiple states have enacted near-total abortion bans. The evidence is accumulating that these laws reduce the obstetric workforce, deter medical students from training in affected states, and create clinical paralysis when physicians face pregnancy complications that technically qualify as emergencies but carry legal risk. Maternal mortality in states with abortion bans is a topic that requires its own post. But anyone reading these scatter plots should understand that the political and clinical environments are not separate.

What the Federal Budget Just Did to These States

On July 4, 2025, the One Big Beautiful Bill Act was signed into law. The legislation cuts federal Medicaid funding by approximately $1 trillion, or roughly 15%, over ten years. The nonpartisan Congressional Budget Office estimates that 11.8 million individuals will directly lose Medicaid health insurance coverage as a result, with an additional 3.1 million losing Medicaid coverage under marketplace plans.

The states that are highest on both mortality scatter plots are the states where Medicaid coverage of births is most concentrated. Families USA estimates that more than half of births in Louisiana, Mississippi, and Oklahoma are financed by Medicaid. The National Partnership for Women and Families has estimated that more than 140 labor and delivery units will close under the cuts. The National Rural Health Association projects rural hospitals will face as much as $70 billion in reduced funding. These are not distant projections -- they describe what happens to the clinical infrastructure of the states already sitting in the upper-right quadrant of both graphs.

The law also introduces new administrative work requirements for Medicaid eligibility, which the Commonwealth Fund and multiple maternal health organizations have identified as creating particular risk for women of reproductive age who are not employed for pay due to childcare, illness, or school attendance. Consistent coverage before, during, and after pregnancy is not optional -- it is how preventable maternal deaths get prevented. Gaps in coverage during pregnancy are associated with delayed prenatal care, unmanaged chronic conditions, and worse outcomes at delivery. Forty-eight states had extended postpartum Medicaid coverage to 12 months. The cuts put that extension at serious risk as states face budget shortfalls they did not choose.

What Patients Should Know

If you live in a state with a maternal mortality rate above 30 per 100,000 live births -- Tennessee, Mississippi, Louisiana, Georgia, Kentucky among them -- you should know that the risk difference between your state and a lower-mortality state is not explained just by biology or by the complexity of your pregnancy.

It is explained largely by the healthcare system around you: how many OB/GYNs practice in your county, whether the nearest hospital has a labor and delivery unit, whether your insurance covers your prenatal visits without administrative barriers.

Medicaid is not a safety net program for someone else.

It is the program that financed your neighbor’s delivery, your county’s only OB, and potentially your own postpartum care. When 11.8 million people lose Medicaid coverage, the effects do not stay within that group. They ripple through clinics and hospitals that serve mixed-payer populations and that may no longer be financially viable when a substantial share of their revenue disappears.

Ask your state legislators whether they plan to maintain the 12-month postpartum Medicaid extension. Ask your congressional representatives how they voted on the One Big Beautiful Bill Act. These are not abstract policy questions. They are questions about whether the labor and delivery unit nearest you will still be open in three years.

My Take

I have been practicing obstetrics for more than 50 years. I have watched maternal mortality statistics be debated, dismissed, recalculated, and reframed. What I know from that experience is this: a maternal mortality rate of 41 per 100,000 in Tennessee and 10 per 100,000 in California does not reflect a difference in how sick or complex those patients are.

It reflects a difference in resources. Period.

The scatter plots circulating in health policy circles are not partisan attack documents. They are descriptive epidemiology with an honest methodological caveat -- ecological association, not individual causation -- printed right on the chart. The researchers who produced them were transparent. The correlation is real, the mechanisms are identifiable, and the policy response is now law.

The states where mothers are most likely to die from pregnancy-related causes will absorb cuts to the very program that finances those mothers’ care. The states where neonatal mortality is highest will lose labor and delivery units in rural counties that already have too few. We are not predicting a possible future outcome. We are describing the predictable consequence of cutting $1 trillion from Medicaid in a country where Medicaid is the largest single payer for childbirth.

These two scatter plots show a correlation. The federal budget signed on July 4 is about to run a natural experiment on whether that correlation can be made worse.

My prediction: yes, it can.

If you are a free subscriber and you found this useful, a paid subscription supports independent, evidence-based coverage of the questions in women’s health that the major professional societies too often leave unanswered.

References

1. CDC/NCHS. Maternal deaths and mortality rates by state, 2018-2022. National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/ [As shown in graph source line; individual state-level report citation to be confirmed -- VERIFY DOI/URL]

2. America’s Health Rankings. Analysis of CDC/NCHS linked birth/infant death records via CDC WONDER, 2022-2023. United Health Foundation. Available from: https://www.americashealthrankings.org [VERIFY current URL]

3. Joyce D, Marceno L, Eisen H. Medicaid cuts could increase maternal mortality and jeopardize women’s health. Commonwealth Fund; May 2025. Available from: https://www.commonwealthfund.org/blog/2025/medicaid-cuts-could-increase-maternal-mortality-and-jeopardize-womens-health

4. Guttmacher Institute. New federal Medicaid cuts will devastate coverage for reproductive health care; November 2025. Available from: https://www.guttmacher.org/2025/11/new-federal-medicaid-cuts-will-devastate-coverage-reproductive-health-care

5. Georgetown University Center for Children and Families. Pregnant women, infants, young children are not protected in proposed Medicaid cuts; July 2025. Available from: https://ccf.georgetown.edu/2025/07/01/worth-repeating-pregnant-women-infants-young-children-are-not-protected-in-proposed-medicaid-cuts/

6. National Partnership for Women and Families. At risk: critical Medicaid benefits for moms; April 2025. Available from: https://nationalpartnership.org/report/at-risk-critical-medicaid-benefits-for-moms/

7. Congressional Budget Office. Estimated budgetary effects of H.R.1, One Big Beautiful Bill Act; 2025. [VERIFY final CBO report citation and DOI]

8. Families USA. The biggest threats to maternal health lurking in President Trump’s health care cuts; September 2025. Available from: https://familiesusa.org/resources/the-biggest-threats-to-maternal-health-lurking-in-president-trumps-health-care-cuts/

A patient comes in and tells me her periods have been “all over the place.”

“When was your last period?” I ask.

She pauses. “Maybe... two months ago? Or three?”

“And before that?”

“I’m not sure. They’ve just been weird.”

This conversation happens constantly. And I get it—when cycles become unpredictable, it’s tempting to stop paying attention. But perimenopause and menopause are exactly when tracking matters most.

Your Body Is Rewriting the Rules. Numbers Help You Follow Along.

For decades, your body ran on a fairly predictable schedule. Then, usually somewhere in your 40s, things start to shift. Periods come early, then late, then not at all, then suddenly back again. Sleep gets harder. Your internal thermostat seems broken. Moods swing without warning.

This is perimenopause—the years leading up to menopause, when your ovaries are gradually winding down estrogen production. It can last anywhere from a few years to a decade. Menopause itself is simply the point when you haven’t had a period for 12 consecutive months.

The transition is normal. But “normal” doesn’t mean you have to navigate it blind. The more you know about what’s happening, the better you can work with your doctor to decide what—if anything—you want to do about it.

The rest of this post is for paid subscribers.

Read more

The phone rings at 2 a.m. A patient tells me she has a fever and doesn’t feel right.

“How high is your temperature?” I ask.

Silence. Then: “I don’t know. I just feel warm.”

This happens more often than you’d think. And it’s not just fever. Blood pressure, baby movements, when bleeding started, how many weeks pregnant—these numbers matter. They change what I tell you to do. They can change everything.

Your Body Sends Signals. Numbers Help Translate Them.

Pregnancy asks a lot of your body. Your blood volume increases by nearly 50 percent. Your heart pumps harder. Your immune system shifts. Your body is doing something extraordinary, and it communicates with you the whole time.

The problem is that pregnancy also brings so many new sensations that it’s hard to know which ones deserve attention. A headache might be dehydration. Or it might be the first sign of preeclampsia, a dangerous blood pressure condition. The difference often comes down to a number.

When you call your doctor or midwife with a concern, we’re trying to figure out where you fall on a spectrum—from “completely normal” to “come in right now.” The more specific you can be, the better we can help.

The rest of this post is for paid subscribers.

Subscribe now

Read more

The Question

It appears on Reddit and Social Media constantly, in a hundred variations.

A pregnant woman has a baby in breech presentation and wants a home birth.

Or she is working 65-hour weeks, sleeping five hours a night, eating at her desk.

Or she hasn’t gained enough weight or too much.

Or the doctor told her there isn’t enough fluid (or too much fluid) around the baby.

She is exhausted and frightened, and at some point -- usually late at night -- she opens her phone and types something like this:

Has anyone else navigated this _____ while pregnant? Did your baby turn out healthy and hit their milestones normally?

The thread fills within hours. Dozens of women answer. Most say: yes, I did it, my baby is perfect, you will be fine. The original poster thanks everyone, feels reassured, and goes back to work.

I want to talk about the word fine.

Because fine is doing an enormous amount of work in that thread, and almost none of it is medical.

What Fine Actually Means

Years ago I faced a medical problem of my own -- not obstetric, but serious enough that I needed a specialist. I asked her directly: will the outcome be fine? She said yes, it will be fine.

I am a physician. I know how to ask a follow-up question. So I asked: what percentage of patients with this problem have a good outcome?

She said: seventy to eighty percent.

I want to sit with that for a moment. Seventy to eighty percent. In most contexts, that sounds reassuring. Most people do well. The majority comes through. And by any reasonable definition of the word, she was not lying when she said fine.

But for me, personally, a twenty to thirty percent chance of a bad outcome was not fine. Not even close to fine. It was frightening, it demanded a serious conversation about options, and it changed every decision I made from that moment forward. The word fine had hidden that entirely. It had taken a probability that deserved to be named and buried it under a single syllable of reassurance.

That experience changed how I think about the language of risk. And it is exactly what happens every time a pregnant woman asks Reddit if her baby will be okay and gets back a chorus of yes, mine was fine.

Why “My Baby Is Fine” Is Not Evidence

During World War II, the RAF examined bullet holes in bomber aircraft that returned from missions. The early instinct was to add armor wherever the holes were clustered. A statistician named Abraham Wald pointed out the error: they were only looking at the planes that came back. The planes that were hit in other places did not return. The holes on the survivors told you nothing about where armor was needed -- only where a plane could be hit and still fly home.

This is survivorship bias. It runs straight through every Reddit thread where a pregnant woman asks if other people’s babies turned out fine. The women who answer are the women who are there to answer. Their babies are fine. The women whose pregnancies went differently are less visible in that thread. Some are in a different community entirely. They are not absent because their experience did not happen. They are absent because survivorship bias selects for who shows up.

When a dozen women write “my baby is fine,” the correct interpretation is not: Having a breech at home is fine. Overwork during pregnancy is safe. Not eating the right food is fine.

It is: some women who worked extremely hard during pregnancy had healthy babies. These are not the same statement. One is a personal outcome. The other would be a population-level claim about risk. Personal outcomes, however numerous and however warmly shared, do not become population data. Only the full distribution of outcomes -- including the ones that did not make it into the thread -- can tell you what the risk actually is.

How Doctors Are Trained to Think Differently

When a patient presents a question like this in a clinical encounter, a physician’s training pulls in a completely different direction than Reddit’s instinct does. The community asks: did it work out for you? The physician asks: what does the data show across all the women who faced this situation?

These are fundamentally different questions. The community’s question selects for survivors. The physician’s question tries to account for all outcomes. A physician who has read the literature knows that sustained overwork during pregnancy -- long working hours, high job strain, chronic sleep deprivation -- has been associated in multiple studies with increased risks of preterm birth, low birth weight, and hypertensive disorders of pregnancy. The absolute risk increase for any individual woman is modest. But it is real, it is biologically plausible, and it is not cancelled out by a hundred reassuring replies online.

This is why physicians speak in probabilities rather than anecdotes. Not because they are cold, but because the anecdote of the survivor is structurally unable to tell you the risk. Only population data can do that.

The Informed Consent Obligation

There is a second dimension here that matters more than the statistics alone. Physicians have a legal and ethical obligation to provide informed consent. This means a patient facing identifiable medical risk has the right to receive complete information: what the risks are, what the evidence shows, what can be done to reduce those risks, and what symptoms should prompt her to call. This obligation does not disappear because the patient did not explicitly ask. It does not disappear because the visit is only 15 minutes. It does not disappear because Reddit already told her she would be fine.

Informed consent is not the same as informed reassurance. Reassurance selects the information that makes someone feel better. Informed consent requires providing all the relevant information -- including the uncomfortable parts -- so that the patient can make genuinely autonomous decisions. The woman working 65-hour weeks has a right to know that the evidence links that pattern to modestly elevated risk of preterm birth. She has a right to know her blood pressure trend, whether fetal growth is on track, and at what point she should call. Armed with that information, she can make a real choice. Without it, she is making decisions in the dark, guided by a word -- fine -- that has been stripped of all its numbers.

My own experience taught me that fine is only meaningful when you know what it is measuring. Seventy to eighty percent good outcomes is not fine for everyone. For some patients it will be acceptable. For others it will be the most important number they have ever heard. They deserve to hear it either way. The word fine should never be allowed to stand alone.

My Take

Reddit gives pregnant women solidarity, and solidarity has real value. It tells her that other people have been in this situation and come through it. That is not nothing. But solidarity is not a substitute for a probability, and a probability is not a substitute for a full informed consent conversation.

When I ask a physician about my outcome and she says fine, and I have to ask a follow-up question to discover that fine means a one-in-five chance of a bad result -- something has already gone wrong in that encounter. The patient who does not know to ask the follow-up question will leave believing something that is not true. That is the failure this post is about.

The next time a pregnant patient asks you whether her situation is fine, I would encourage you to resist the word entirely.

Tell her what you know.

Tell her the number.

Tell her what you are watching for, and why.

Let her decide what fine means to her.

She is capable of handling the information. She deserves to have it. And she should not have to go to Reddit at two in the morning to find out that you left something out.

Grace did not get a birth certificate for her son. She got a small white coffin.

She had hired an unlicensed free birth attendant. As Grace’s legs swelled and her blood pressure climbed, the attendant told her it was normal. Women’s bodies were designed for this. By the time she reached the hospital, her son was dead. Undiagnosed preeclampsia. Had she seen an obstetrician at 36 or 37 weeks, she would have been induced or delivered immediately. That is not a hypothetical. That is the standard of care that exists precisely because this happens.

Grace’s story appeared in the New York Times this week. It is not the only one.

What Free Birth Actually Is

Free birth means delivering a baby with no doctor, no midwife, and no prenatal care. Its promoters call it reclaiming childbirth from an over-medicalized system. What it actually does is remove every safety mechanism that exists because labor can turn lethal in minutes.

This is not a fringe curiosity anymore. The Free Birth Society, founded in 2017, now has 132,000 Instagram followers and a podcast with more than five million downloads. One of its signature courses costs $399. It teaches women that obstetrics is, quote, “the story of rape, abuse, harm, violation.” It teaches them that vaginal exams during labor are comparable to being fondled. It sells baseball caps that say Make Birth Great Again.

This is not education. It is radicalization dressed in linen.

Subscribe now

The Deaths Are Not Anecdotes

In Ontario, Canada, coroners investigated free birth deaths between 2020 and 2024. They found 11 stillbirths or neonatal deaths and one maternal death linked to free births in those four years. In the five years before, there had been one. That is not a trend. That is a body count.

In Australia, a natural food influencer died last September of a suspected postpartum hemorrhage after a free birth. Postpartum hemorrhage is one of the leading causes of maternal death worldwide. It is also one of the most treatable conditions in a clinical setting. Minutes matter. Twenty miles to the nearest hospital, as Emily Laszlo-Rath discovered in her trailer outside Joshua Tree, is a different calculation entirely.

Even the founder of the Free Birth Society, Emilee Saldaya, delivered a stillborn baby at 41 weeks last August. She had promoted free birth throughout her own pregnancy on social media, rubbing her bare belly in videos superimposed with a list of all the prenatal care she had skipped. She has continued selling courses since.

The CPM Problem: Counterfeit Pretend Midwives

The New York Times quoted Mickey Sperlich, described as a certified professional midwife and associate professor of social work, who said this: “Safety is relative.”

I want to be precise about what a certified professional midwife is.

A CPM is not a certified nurse-midwife.

A CNM completes graduate-level nursing education, passes a national board examination, and is licensed in all 50 states.

A CPM does not require a nursing degree. The educational requirements vary widely by state. In much of the United States, CPMs are not licensed at all. Parents should know.

I call them Counterfeit Pretend Midwives. That is not a slur. It is a credential audit.

And this particular CPM told a national newspaper that safety is relative. For some people, she explained, safety means modern medicine. For those who have experienced mistreatment, safety “perhaps becomes something different.”

Subscribe now

You might disagree with her statement on “relative risk”, but even doctors support the notion that “relative risk” is not something women considering a home birth should be worried about. The argument that absolute risk should guide physician participation in home birth and not relative risk sounds reasonable on the surface — but it collapses when the absolute risk it minimizes is a preventable neonatal death. Telling a family that the increased risk is “small in absolute terms” is a statistical comfort that arrives, if it arrives at all, after the funeral.

Tell that to Grace. Tell it to the 11 families in Ontario. Tell it to the husband in Australia who buried his wife.

The Legitimate Grievance Underneath a Dangerous Movement

I have been in obstetrics for more than 50 years. I know that the medical system has failed many women. A 2019 survey published in Reproductive Health found that one in six women who received maternity care in the United States reported experiencing mistreatment. That number is not acceptable. The fear of hospitals, the distrust of institutions, the sense that something was done to you rather than for you -- these are real, documented experiences.

But “the medical system has sometimes failed women” does not lead logically to “therefore, deliver alone in a trailer with no prenatal care.” That is not a conclusion. That is despair dressed as empowerment.

The correct answer to obstetric mistreatment is better obstetric care, better access to certified nurse-midwives, better accountability for providers who harm patients. It is not to tell women that their instincts will protect them from preeclampsia, fetal growth restriction, postpartum hemorrhage, or uterine infection. Nature did not design labor to be safe. We spent two centuries building the infrastructure that made it survivable for most women.

What Prenatal Care and Skilled Attendance Actually Do

Preeclampsia, the condition that likely killed Grace’s son, has no symptoms in early stages. You cannot feel a rising blood pressure. You cannot see elevated liver enzymes. What you can do is measure both, at every prenatal visit, precisely because they can progress silently and quickly to a state where the baby cannot survive and the mother cannot either without emergency intervention.

Fetal growth restriction -- when a baby is not growing properly -- can be identified only by ultrasound. A baby that is not growing is a baby at elevated risk of stillbirth. You cannot detect this by monitoring fetal movement. You cannot detect it by trusting your body. You detect it by measuring the baby.

Postpartum hemorrhage -- the condition that killed the Australian influencer -- can begin within minutes of delivery and become fatal within an hour. The treatment is oxytocin, uterine massage, and if necessary, surgical intervention. None of these are available in a home setting without trained personnel and prepared medications.

These are not rare edge cases. They are among the leading causes of maternal and neonatal death. They exist on a spectrum from mild to catastrophic. The difference between the mild and the catastrophic is often measured in minutes and in the proximity of someone who knows what to do.

My Take

The Free Birth Society sells a $399 course that teaches women that obstetrics is violence. It then provides a disclaimer that the instructors are not medical providers and that the content is not medical advice. That disclaimer is not a legal technicality. It is an admission. They know they are not qualified to give the guidance they are selling. They are charging for it anyway.

When a CPM tells the New York Times that safety is relative, she is not offering a philosophical observation. She is providing cover for a movement that is killing babies and mothers. The philosophical flexibility ends at the autopsy report.

Respect for patient autonomy is a cornerstone of medical ethics. I have believed that for 50 years and I still believe it. But autonomy requires accurate information. Informed consent requires that the person making the choice understands the actual risks of the option she is choosing. What the Free Birth Society provides is the opposite of informed consent: it is misinformation designed to amplify fear of medicine and suppress fear of the one setting where patients have no safety net.

Emily Laszlo-Rath arrived at the hospital septic, dehydrated, and in active labor. She left with a healthy son. She knows exactly what saved her. “I just didn’t listen to my own mom,” she said. “I decided to listen to all these other people that I didn’t even know.”

Those other people are still selling courses.

If this post matters to you, subscribe to ObGyn Intelligence at obmd.com. Evidence-based obstetrics for clinicians and patients who want the truth, not the trend.

References

1. MacKeen D. ‘Free Births’ Are a New Pregnancy Trend. Critics Warn About Serious Risks. New York Times. 2026 Apr 22.

2. Vedam S, Stoll K, Taiwo T K, et al. The Giving Voice to Mothers study: inequity and mistreatment during pregnancy and childbirth in the United States. Reprod Health. 2019;16(1):77.

3. Office of the Chief Coroner for Ontario. Free birth-related deaths 2020-2024 [reported in New York Times, 2026 Apr 22].

4. American College of Obstetricians and Gynecologists. Planned Home Birth. Committee Opinion No. 697. Obstet Gynecol. 2017;129:e117-e122.

5. National Center for Health Statistics. Births: Final Data for 2024. National Vital Statistics Reports. 2025.

A woman three weeks postpartum posted a public service announcement on Reddit to r/pregnant urging all expectant mothers to unfollow every mom influencer and curated account before their baby arrives. She described spending her pregnancy inspired by polished mommy content, only to find her newborn reality bore no resemblance to it.

The post received 572 upvotes and 80 comments.

The comment section amplified her message with personal accounts of guilt, low self-esteem, and worsened postpartum mental health tied to social comparison. Multiple commenters disclosed they had deleted social media entirely in the postpartum period and reported significant improvement in their mental health. One commenter who knew a mom influencer personally detailed the full infrastructure behind the content: a live-in maid, a gardener, laundry services, a personal trainer, cosmetic procedures, and family members who did childcare full time. A small minority pushed back, arguing the problem is individual media literacy rather than the content itself.

The Clinical Issue: Postpartum Social Comparison

There is no diagnostic code for postpartum social comparison, but the harm it causes is real and clinically relevant. The postpartum period involves a sharp drop in estrogen and progesterone, disrupted sleep, physical recovery from birth, and the cognitive demands of newborn care. These factors reduce emotional resilience and amplify the impact of external stressors, including social comparison. Postpartum depression affects roughly 10 to 15 percent of new mothers; postpartum anxiety is at least as common and more underdiagnosed. Social media use in the general population is associated with increased rates of both. Curated influencer content does not present a peer experience. It presents a production, often supported by paid staff and hidden resources. A new mother comparing herself to that production is not engaging in a fair comparison. She is comparing her private reality to someone else’s edited product, at the moment she is least equipped to maintain perspective.

What It Means: The Evidence

The research on idealized motherhood content and maternal mental health has become more specific in recent years. A 2022 experimental study exposing 464 new mothers to idealized Instagram motherhood posts found that such content increased anxiety and envy compared to non-idealized posts, with mothers who had a higher tendency toward social comparison showing the greatest reduction in perceived parenting competence.

(1) A 2025 systematic review examining the impact of parenting-based social media influencers found consistent evidence that exposure to mom-influencer content was associated with reduced maternal self-efficacy, body dissatisfaction postpartum, and feelings of inadequacy and shame.

(2) A separate literature review across 16 studies found that social media functions as both a risk factor and a protective factor for postpartum depression, with harm driven specifically by social comparison, exposure to idealized motherhood content, and health misinformation, while benefit came primarily from peer support and educational content.

(3) The evidence does not establish simple causation, and no large randomized controlled trial exists on this specific question. What the literature does establish is a consistent directional signal: passive consumption of curated motherhood content in the postpartum period is associated with worse mood and lower parental confidence, and the women most biologically vulnerable to this harm are exactly those in the newborn period.

The research on social media and maternal mental health is not yet definitive, but the direction of the evidence is consistent.

Studies examining social media use in the perinatal period have found associations with higher rates of depressive symptoms, lower self-efficacy as a new parent, and increased body dissatisfaction postpartum. The mechanism is not complicated: sustained exposure to idealized depictions of motherhood raises implicit benchmarks against which women measure their own performance, and new mothers experiencing normal newborn difficulty interpret that gap as personal failure.

Several comments in this thread named specific content categories as particularly harmful: pump output videos that imply breastfeeding success is measured in ounces; “two weeks postpartum” body content that presents atypical recovery as normal; and “day in the life” videos that conceal the staff, resources, and editing required to produce them. These are not edge cases. They are dominant content formats in the mom influencer space.

The thread also surfaced a partner exposure problem. At least two commenters described partners citing TikTok content as a benchmark for what the pregnant or postpartum woman should be doing: renovating nurseries at 38 weeks, exercising throughout pregnancy, recovering quickly after birth. This extends the harm beyond the individual viewer. Clinicians routinely discuss prenatal nutrition, sleep, and exercise with patients. A brief conversation about social media and realistic postpartum expectations costs five minutes and has no documented downside. There is more evidence for that conversation than for several items currently standard in prenatal care.

Doximity is where doctors go at 2 a.m.

This week’s thread comes from Doximity’s Op-Med forum, a physician-only platform where, it turns out, doctors can be just as unfiltered as anonymous internet users, only with credentials.

An Op-Med essay arguing that cash-based care is an ethical response to a broken system drew 69 comments and 51 upvotes from physicians across specialties. The arguments ran the full spectrum: libertarian (no one has a right to another’s labor), structural (insurance is the real villain), practical (DPC works for routine care, not for catastrophes), and moral (concierge medicine serves the privileged, abandons the rest).

Missing almost entirely: any acknowledgment that physicians carry a professional obligation that distinguishes us from plumbers, hair stylists, and tax accountants: the comparison several commenters volunteered without apparent irony.

The thread is a useful artifact of how physicians rationalize individual exit strategies as ethical acts while the system they are exiting continues to fail the patients who cannot follow them out the door.

Evidence-Based Commentary

Let us start with the ethical sleight of hand at the center of this entire debate.

The Op-Med essay frames cash-based care as an ethical response to a broken system. That is a grammatically coherent sentence that collapses under the slightest pressure. An ethical response to a broken system is one that works to fix it, advocates for patients within it, or at minimum does not make it harder to fix by removing the physicians most capable of demanding change. Opting out and calling it ethics is not a response -- it is a resignation letter dressed up as a manifesto.

The most upvoted comment in the thread (44 upvotes) argues that health insurance stopped being real insurance when it began covering routine care, comparing it to auto insurance that does not pay for oil changes. This analogy is rhetorically satisfying and analytically useless. An oil change does not prevent your car from catastrophically failing and killing other people on the highway. Untreated hypertension, gestational diabetes, and cervical dysplasia are not oil changes. The entire moral architecture of medicine -- from the Hippocratic tradition to modern bioethics -- is built on the premise that medical care is not a commercial transaction like any other, precisely because the stakes are different and the information asymmetry between physician and patient is profound.

Several commenters invoked the plumber comparison. A plumber charges what the market will bear; why should a physician be different? Because a plumber has not taken an oath. Because a plumber is not granted a legal monopoly on a service that people cannot survive without. Because medical licensing exists as a social contract: society grants physicians extraordinary privilege -- prescription authority, hospital access, legal protections -- and in exchange, physicians accept professional obligations that ordinary tradespeople do not carry. The moment you cash that check, you have agreed to the terms. You do not get to redesign the contract when it becomes inconvenient.

The professional responsibility framework, which I have applied in my work for decades, is unambiguous on this point. Professional responsibility is not a preference. It is not a lifestyle choice contingent on favorable reimbursement rates. It is the foundational ethical obligation that justifies the profession’s existence and its social privileges. When physicians frame individual practice decisions as ethical acts without accounting for their population-level consequences, they are not doing ethics, they are doing rationalization.

The structural critique buried in this thread is legitimate and largely correct: insurance as currently constituted is extractive, bureaucratic, and organized primarily around the financial interests of intermediaries rather than patients. This is empirically true. It does not follow, however, that the ethical corrective is for individual physicians to exit the system and serve a smaller, wealthier panel. That is precisely analogous to arguing that because public schools are underfunded, private school tuition is an ethical act. It describes a personal solution. It does not constitute a remedy.

The only ObGyn voices in this thread -- Donna Ivery and Jocelyn Fitzgerald -- both point in the right direction. Dr. Ivery notes that the American healthcare system has always been tiered and inequitable, and that concierge medicine is simply another iteration of a structure that has never served everyone. Dr. Fitzgerald’s brief contribution -- ‘This is what is happening in endometriosis care’ -- says everything. Endometriosis takes an average of seven to ten years to diagnose. That delay is not shortened by cash-pay practices for patients who can afford them. It is shortened by structural accountability, better training, and a healthcare system that takes women’s pain seriously regardless of income. The cash-based model addresses none of that.

One comment from a rheumatologist deserves particular attention for its precision: concierge practice may improve physician service delivery for patients without Medicaid, but it does nothing to address the largest patient costs, laboratory studies, imaging, emergency department visits, hospitalizations, or specialty medications. This is correct.

The entire cash-based care argument addresses the least expensive component of a patient’s healthcare expenditure and leaves the catastrophic costs entirely untouched. A patient in a DPC practice who develops ovarian cancer, a pulmonary embolism, or preeclampsia is not protected by her monthly subscription fee. She is on her own with whatever insurance she could afford -- which in a DPC model, the physician conveniently will not be managing.

Finally, the ethics framing itself demands scrutiny. The original essay argues that in a broken system, cash-based care may be an ethical response. May be. The epistemically humble hedge of a conclusion that cannot survive direct examination. Real ethical analysis requires asking not only whether an action is permissible for the individual, but what the consequences are for those who cannot make the same choice. In bioethics, we call this the justice principle. It is not optional. A practice model that improves care for patients who could already navigate the system adequately, while accelerating the deterioration of care for patients who cannot, fails the justice analysis regardless of how liberating it feels for the physician choosing it.

What It Means

The cash-based care debate is a symptom of genuine physician burnout, administrative burden, and a reimbursement system that undervalues primary and preventive care. These are real problems. The ethical response to real problems, however, is not to reframe personal accommodation as moral courage. When physicians argue that opting out is ethical because the system is broken, they are making a claim that requires them to account for who gets left behind when they leave. That accounting is notably absent from this thread and from most cash-based care advocacy. Professional ethics in medicine is not satisfied by improving your own working conditions. It requires attending to the obligations that exist precisely because physicians hold a privileged position in society -- obligations that persist even when, especially when, the system makes honoring them inconvenient.

My Take

I have been inside this system for more than 50 years. I have delivered over 10,000 babies, directed a large Labor and Delivery unit, fought with insurers, navigated administrative nightmares, and watched colleagues burn out in real time.

I understand the appeal of opting out. I understand it viscerally.

But I cannot call it ethics. Nor should you.

The physicians in this thread who invoke libertarian philosophy, no one has a right to another’s labor, are technically correct and professionally irrelevant.

Of course no one has a claim on your labor in the abstract. But you chose medicine. You accepted the license, the privileges, the title, and the social trust that comes with it. That trust was built by generations of physicians who did not opt out when things got hard.

Calling your exit strategy an ethical act does not make it one. It makes it a rationalization, and a well-upvoted one, at that.

The obstetricians in this thread mostly said the right things. The rest of medicine has more work to do.

Summary

A first-time mother posted on r/pregnant describing 85 hours of active labor during which she was sent home from the emergency department twice after being told she was “1 cm and a wiggle” dilated. She appeared for a scheduled OB appointment -- which she almost skipped -- and her physician found her at 9.5 cm. She delivered the same day.

The post collected 429 upvotes and 53 comments. The community response was largely one of shared recognition: stories of similar dismissals poured in, including a commenter who delivered a preterm baby 24 hours after being told her contractions were not real. Several OB and L&D nurses in the comments acknowledged that TOCO monitor numbers do not measure contraction strength -- only frequency and duration -- while also noting that clinical staff routinely fail to explain this to patients.

The post is also a case study in how triage assessment errors compound. At the first visit, the cervix was described as posterior and unreachable. At the second visit, three nurses attempted cervical examination; the TOCO was mispositioned and registered near-zero values during contractions. The patient was sent home both times. She ultimately had to be persuaded by her OB to undergo the exam that revealed imminent delivery.

Evidence-Based Commentary

This post encodes four distinct clinical failures, each independently capable of causing harm, each compounded by the next. They deserve to be named precisely, not laundered as “prodromal labor” -- a term that appeared in the comments and that, while technically defensible, functions here as an explanation that excuses rather than examines.

But first of all, nobody asked if this was her first baby or not. Because that information is essential to try understanding what went on. Prior labors were fast, this will be again. First baby, and labor more likely longer.

• The first failure is cervical examination technique. A posteriorly positioned cervix in early labor is not an anatomical surprise -- it is an expected finding. Standard obstetric teaching holds that a posterior cervix should be identified, documented with Bishop score components (position, consistency, effacement, dilation, station), and followed. The documented inability to reach the cervix at the first visit was not accompanied by any attempt to note cervical position, effacement, or station. “1 cm and a wiggle” is not a clinical finding; it is an estimate made under suboptimal conditions and communicated without a confidence interval. When three nurses are required to attempt the same exam at the second visit and arrive at the same number under worse monitoring conditions, that is a signal, not reassurance.

• The second failure is TOCO interpretation and patient communication. The external tocodynamometer measures uterine wall movement, not intrauterine pressure. It is a measure of contraction frequency and duration -- not strength. This is not obscure physiology. It is in every obstetric nursing textbook. The nurse’s response at the second visit -- that contractions reaching 15 on the monitor “don’t really matter” -- is clinically accurate in isolation. TOCO numbers do not correlate with cervical change. But the framing weaponized accuracy against the patient. The appropriate response to a TOCO reading that contradicts clinical presentation is not “those numbers don’t matter” -- it is manual uterine palpation to assess contraction firmness, combined with re-examination. Neither occurred.

• The third failure is the use of pain tolerance as a diagnostic criterion. “You’ll know when it’s real labor because it’s really painful” is not a triage standard. It is an assumption built on population averages that collapses in the face of individual variation, high pain tolerance, neurodivergent sensory processing, stoicism, or simply a labor pattern that progresses faster than the screaming-woman heuristic anticipates. Pain behavior correlates poorly with cervical dilation across individuals. A patient presenting repeatedly, over multiple days, with contractions 1.5-2 minutes apart has already provided the clinical signal. The decision to override that signal with behavioral expectations is not evidence-based practice.

• The fourth failure is the most systematic: the absence of a safety netting plan. Both ER visits ended with discharge and no documented return precautions, no scheduled recheck at a defined time interval, and no instruction to call the OB before the next scheduled appointment. A patient in possible prodromal or early labor with a posteriorly positioned cervix should leave triage with explicit criteria: return if contractions reach X frequency, if membranes rupture, if fetal movement changes, or if pain becomes intolerable -- and with a low threshold for same-day OB contact. This patient almost did not go to her OB appointment because she had internalized the triage assessment. That near-miss is the consequence of inadequate safety netting, not inadequate patient judgment.

One comment in the thread deserves attention: a nurse wrote that TOCO numbers “truly don’t mean anything to us” -- and 103 people upvoted it. This sentiment is intended to be reassuring.

It functions instead as a description of a communication failure that predates this case and will outlast it. If a monitoring tool’s numbers do not mean anything to clinical staff, patients need to know that explicitly, in plain language, at the time the monitor is applied. What it actually measures. What it does not measure. What assessment will be used instead. That is informed consent for the monitoring process itself. Its absence here is not a minor oversight; it is why a woman spent 85 hours convinced that her body was lying to her.

What It Means

Labor triage errors are not rare. They are structurally predictable when assessment protocols rely on a single cervical measurement, TOCO numbers are allowed to override clinical judgment, and pain behavior is used as a proxy for dilation. This case is unusual in outcome -- 9.5 cm at an outpatient OB appointment -- but the pattern of dismissal it describes appears dozens of times in the comments alone. The comments are not outliers. They are prevalence data.

For clinicians, the actionable question is not whether this particular case could have been handled differently -- it obviously could. The question is what structural conditions allow this pattern to recur. The answer points to three specific gaps: incomplete cervical assessment documentation (Bishop score vs. a single number), no protocol for manual palpation when TOCO is unreliable, and no standardized safety netting language at labor triage discharge. None of these require new equipment. They require explicit expectations and the teaching to back them up.

The comment from the L&D nurse who said TOCO numbers “don’t really matter” is not wrong -- and it is also not good enough. Clinical staff knowing that TOCO is limited while patients believe it is the definitive labor meter is a communication gap with real consequences. Closing that gap is not the patient’s responsibility.

My Take

I have been in labor and delivery for five decades. I have seen this. The specific details change; the shape of it does not. A patient knows something is happening. She is told she does not. She eventually turns out to be right -- sometimes before a bad outcome, sometimes after.

What troubles me most about this case is not the triage failures, though they are real and correctable. It is the moment when this patient almost refused her OB appointment -- because she had been told enough times that her body was wrong that she believed it. She arrived at that appointment apologizing, promising her doctor she was not in active labor. She was 9.5 cm dilated and crying in pain.

The OB in this story did everything right. She insisted, with kindness, on a cervical exam. The look on her face when she found 9.5 cm is the image that stays with me. That look is the gap between what the system told this woman and what was actually happening inside her body. We close that gap not with better TOCO monitors but with better communication, better examination standards, and the professional honesty to tell patients exactly what our tools can and cannot measure -- before they spend 85 hours doubting themselves.

What Is Decreased Fetal Movement?

Decreased fetal movement (DFM) means a pregnant woman notices her baby moving less than usual. It is one of the most important warning signs in the third trimester. Fetal movement reflects fetal wellbeing. A baby that is stressed, compromised by placental dysfunction, or suffering from reduced oxygen delivery will often reduce its movement to conserve energy. This is the biology behind why DFM matters.

DFM does not mean the mother imagined it. It does not mean she is overreacting. It does not go away by drinking cold water or lying on her left side. Those interventions are outdated and, more importantly, they delay evaluation. The UK’s NICE guideline explicitly advises women not to try to stimulate movement at home but to contact their care provider immediately. The reason is straightforward: if a baby needs stimulation to move, that is a clinical finding, not a reassurance.

Normal fetal movement varies widely between pregnancies and changes with gestational age. What matters is a change from the individual baby’s established pattern. A woman who knows her baby moves constantly and suddenly notices hours of silence is reporting a clinical symptom, not anxiety. The conditions associated with DFM include placental dysfunction, oligohydramnios (low amniotic fluid), umbilical cord complications, and in severe cases intrauterine fetal demise. Evaluation requires electronic fetal monitoring and, when indicated, ultrasound assessment of fluid and biophysical profile.

The standard of care, supported by evidence and endorsed by ACOG and NICE alike, is this: when a pregnant woman reports decreased fetal movement, she should be evaluated. Not reassured over the phone. Not told to try juice and wait. Evaluated.

Summary

A woman at 28 weeks and 4 days posted to r/pregnant after spending several hours not feeling her baby move. She went to the hospital, where monitoring showed active fetal movement she could not perceive. She felt embarrassed. The post received 168 upvotes and 77 comments. The comment section became a sustained, community-led affirmation that she did the right thing. Multiple commenters shared identical experiences. Several shared experiences where going in led to the discovery of a real clinical problem. Healthcare workers in the thread confirmed without exception that evaluation is always appropriate for decreased fetal movement.

What It Means

The thread documents something clinically important: women are still being made to feel that reporting decreased fetal movement is excessive. This woman was not comforted by her clinical experience. She was embarrassed by it. That embarrassment is a patient safety problem. A woman who feels dumb for going in once is less likely to go in again. That hesitation is where babies are lost.

Do the fetal kick count HERE.

The cases buried in the comments illustrate the clinical reality. One woman reported low amniotic fluid leading to induction. Another described a baby with a critical AFI and placental calcification discovered only because she went in. A third woman needed an emergency cesarean for fetal distress, identified on her second visit in one week, after she almost did not call because she felt she had already been in too recently. In each case, the presenting symptom was what this original poster experienced: a decrease from a known movement baseline.

Subscribe now

The fact that monitoring revealed movement the mother could not feel is not a false alarm. It is a reminder that maternal perception of fetal movement is an imprecise but meaningful clinical tool. Anterior placenta position, fetal position, gestational age, and amniotic fluid volume all affect what a mother can perceive. The monitors pick up what maternal touch cannot. That is the point of going in.

My Take

This thread reveals a gap that no guideline has closed: the space between what evidence says and how women feel when they act on it. Every professional organization that has addressed decreased fetal movement recommends prompt evaluation.

The evidence for maternal perception as an early warning system is not in dispute.

Yet a 28-week patient with a history of an active baby went to the hospital after hours of silence and came home embarrassed.

That is a failure of clinical communication, not of clinical care. The nurses were apparently kind. The evaluation was appropriate. But nothing in her encounter neutralized the social signal she had received somewhere, from someone, that going in for this concern was excessive. The thread normalized her experience in a way her clinical encounter did not.

One comment, from a woman who nearly stayed home because she thought she was imagining things, stood out. She went in. Her AFI was critically low. She was monitored for three weeks and induced at 36 weeks. The placenta had begun calcifying. She wrote: ‘Without the monitoring we wouldn’t have known until it was too late.’ That is the case for going in. Every time.

The clinical message should be framed not as ‘come in if you’re worried’ but as ‘a change in your baby’s movement pattern is a symptom, and symptoms deserve evaluation.’ Worry is subjective. A symptom is a clinical fact. We do not tell patients with chest pain to try lying down first to see if it goes away. We should stop implying that to pregnant women reporting decreased fetal movement.

A woman is 12 weeks pregnant. She calls a doctor’s office for a prenatal appointment. She is told the doctor does not accept her insurance. She calls another office. Same answer. She calls a third.

She is not in a rural area. She is not uninsured. She has coverage. It is just the wrong coverage. And at 12 weeks, with a pregnancy that needs to be seen, she is sitting at home making phone calls instead of sitting in an exam room.

Nobody calls this a reproductive justice issue. But it is!

It does not make the advocacy websites. It does not appear in the policy statements. It is not what reproductive justice organizations march for.

It is just a woman at 12 weeks who cannot find a doctor, because her insurance is the wrong kind, and the movement that was built to protect her has not gotten around to naming it.

That is reproductive injustice.

What Reproductive Justice Means

The term was created in 1994 by a group of Black women at a conference in Chicago. The lead voice was Loretta Ross. The framework they built had three pillars: the right not to have a child, the right to have a child, and the right to parent in a safe and healthy environment.

This was a deliberate expansion beyond abortion rights alone. It centered race, gender, and structural oppression. It said reproductive health cannot be separated from housing, poverty, immigration status, and environmental safety. That framework changed how many advocates and researchers think about women’s health.

It is a good framework. It is also incomplete.

Subscribe now

What It Leaves Out

The reproductive justice movement is largely silent on two things that shape reproductive outcomes more than almost any other factor: health insurance and money.

1. Start with Prenatal care is next. In the United States, Medicaid pays for roughly half of all births. But Medicaid reimbursement rates for obstetric care are, on average, about 50 percent of what private insurance pays. Many of the best-trained obstetricians and maternal-fetal medicine specialists do not accept Medicaid, not because they do not care, but because the math does not work.

   A woman on Medicaid is not getting the same access to care as a woman with private insurance.

   This is not a secret. It is policy.

2. Fertility treatment is a gap almost never mentioned in reproductive justice conversations. The right to have a child is a core pillar of the framework. But in vitro fertilization costs between $12,000 and $15,000 per cycle on average. Only 19 states require any insurance coverage for fertility treatments, and the requirements vary widely. For most women in most of the country, the right to have a child -- when biology does not cooperate -- is available only to people who can pay for it out of pocket.

3. Postpartum coverage is another gap. Medicaid traditionally ended 60 days after delivery. Sixty days. That is when postpartum depression often peaks. That is when many complications become visible. Many states have now extended coverage to 12 months under new federal rules, but not all have done so, and the coverage itself is still Medicaid -- meaning limited networks and the same access problems described above.

4. Contraception is another. The Affordable Care Act required most private plans to cover contraception without cost sharing. But that does not cover everyone. Women without insurance, women in states with religious exemptions for employers, and women whose plans predate ACA requirements can still face significant out-of-pocket costs for contraception.

5. And then there is abortion. The Hyde Amendment has blocked federal Medicaid funding for abortion since 1976. That means a low-income woman on Medicaid in most states has a legal right to abortion -- and no realistic way to pay for it. About 1 in 4 women who want an abortion and are on Medicaid cannot get one because of cost.

Having a right that costs money you do not have is not really having a right.

The Door That Does Not Open

All of that — the Hyde Amendment, the Medicaid reimbursement gaps, the fertility coverage deserts — happens at the policy level. It is invisible. What is not invisible is this: a woman calls an OB’s office, gives her insurance, and is told there are no appointments available. She calls back with a different insurance card and gets an appointment the same week. Or she calls with no insurance at all and is told, politely, that the practice does not offer payment plans.

Doctors and practices have the legal right to decline patients they do not wish to see. Outside of emergency rooms, there is no law requiring a physician to accept any particular insurance or any particular patient. And so, every day, women are turned away from obstetric and gynecologic care not because the doctor is not skilled, not because the office is full, but because her insurance pays too little or she has no insurance at all.

This is not hypothetical. A 2024 study found that Medicaid patients attempting to schedule obstetric appointments were significantly less likely to get one than patients with private insurance, even when calling the same practices. [CITATION NEEDED - check Medicaid access audit studies, e.g. JAMA or Health Affairs] The gap was not subtle. In some markets, Medicaid patients were turned away at double the rate of privately insured patients.

We talk about reproductive justice as though access to care is a given and the only fight is over what happens once a woman is in the door. But the door itself is the problem. A woman who cannot get an appointment for prenatal care in her first trimester because of her insurance card is experiencing reproductive injustice as direct and immediate as any legislative ban. The mechanism is different. The outcome -- a woman without care she needs -- is the same.

And it falls hardest on the women the reproductive justice framework was built to protect. Black women. Latina women. Low-income women. Women in rural areas where the only OB who takes Medicaid is two counties away. The framework named these women. It did not name the receptionist who puts them on hold and never calls back.

Why This Gap Exists

Reproductive justice advocacy grew out of a civil rights tradition. Its natural language is rights and dignity and structural racism. That language is correct and necessary. But rights without resources are rhetoric. The movement has been better at naming what women deserve than at fighting the payment systems that decide what women actually get.

Insurance companies, Medicaid reimbursement rates, hospital billing departments, and federal appropriations committees are not as compelling as the image of a woman being denied care. They are harder to put on a poster. But they determine outcomes in ways that race-focused advocacy alone does not capture.

To be clear: racial disparities in maternal outcomes are real and documented. But the evidence increasingly points to insurance status as a primary driver. Countries with universal coverage show dramatically smaller racial gaps in maternal mortality. The racism is real. The financial mechanism that amplifies it is also real. Both deserve sustained attention.

My Take

The reproductive justice framework gave us something important: a way to think about reproductive health that goes beyond a single procedure or a single right. But it has not gone far enough. Telling a woman she has the right to decide about her pregnancy -- without fighting for the insurance coverage, the Medicaid reimbursement rates, the fertility treatment coverage, and the postpartum support that make that right real -- is not justice. It is a promise without a delivery system.

The next evolution of reproductive justice has to be financial justice. That means fighting Hyde. That means demanding Medicaid parity with private insurance for obstetric care. That means mandating fertility coverage. That means making postpartum Medicaid extension permanent and national.

Rights on paper are a start. Rights you can actually use are the goal.

A 5-degree Celsius rise in average temperature during early pregnancy was associated with a nearly seven-fold increase in the risk of preeclampsia in one study. In another, each 1°C increase in daily temperature added almost 4 additional preterm births per 1,000 live births. These are not projections. These are findings from published epidemiological studies, and they point to a pregnancy risk factor that most clinicians never discuss with patients: heat.

Every summer, millions of pregnant people are exposed to temperatures that research links to serious complications. Yet heat exposure rarely appears on a prenatal checklist. It should.

What Happens to the Pregnant Body in Heat

Pregnancy changes how the body handles heat. Core body temperature drops slightly. The threshold for sweating lowers. Blood volume and skin blood flow increase. These are adaptive changes that help the body dissipate heat more effectively (1,2). The placenta itself generates heat as it transfers thermal energy from the fetus to the mother, increasing the mother’s overall heat load (3).

For healthy pregnant people doing moderate exercise, these adaptations work well. Research shows that pregnant individuals can safely exercise for up to 35 minutes at 80% to 90% of maximum heart rate in conditions of 25°C (77°F) and 45% relative humidity (2). There is no evidence that pregnancy itself increases the risk of heat injury compared to non-pregnant individuals.

But “no increased risk of heat injury” is not the same as “no increased risk from heat.” The real concern is not heatstroke. It is what sustained high temperatures do to the placenta, to blood flow, and to the developing fetus.

The Evidence: Preeclampsia, Preterm Birth, Stillbirth

A time-to-event study of 8,090 births in South Africa examined the relationship between ambient temperature and hypertensive disorders of pregnancy. The findings were striking. Exposure to a mean temperature of 23°C, compared with 18°C, between 2 and 5 weeks of gestation was associated with a significantly increased hazard of preeclampsia (hazard ratio 7.68; 95% CI, 1.72 to 34.28). The absolute numbers tell the story even more clearly: preeclampsia rates were 4.4% among those exposed to 18°C throughout pregnancy, compared to 29.2% among those exposed to 23°C in that critical early window. That translates to approximately 248 additional cases per 1,000 pregnancies (4).

A systematic review and meta-analysis of 47 observational studies, primarily from high-income countries, examined heat and preterm birth. Each 1°C increase in daily temperature was associated with a 1.05-fold increase in the odds of preterm birth (95% CI, 1.03 to 1.07). Against a baseline preterm birth rate of 7.9%, this corresponds to an absolute risk of 8.28%, or 3.8 additional preterm births per 1,000 live births per degree of warming (5).

The same review reported that each 1°C increase in temperature was associated with a 1.05-fold increase in stillbirth risk (95% CI, 1.01 to 1.08) (5). These are small relative increases that, applied across millions of pregnancies, translate to thousands of affected families.

The mechanisms are not fully understood, but the leading hypotheses center on dehydration reducing maternal blood volume, which decreases placental blood flow and raises oxytocin concentrations, potentially triggering preterm contractions (1,3). Heat exposure during pregnancy may also increase systemic inflammation (1).

Mental Health and Heat in Pregnancy

A matched analysis from North Carolina covering 2011 to 2019 found that heat wave periods were associated with a higher risk of severe mental illness among pregnant individuals (relative risk 1.13; 95% CI, 1.08 to 1.19). No association was found between heat waves and perinatal mood or anxiety disorders specifically (6). This distinction matters: the risk appears to affect those with pre-existing severe mental illness, a population that already faces barriers to adequate prenatal care.

Early Pregnancy: Neural Tube Defects

Maternal hyperthermia in early pregnancy has long been recognized as a risk factor for congenital anomalies. During the August 2003 Paris heat wave, when mean daily temperatures exceeded 35°C for 14 consecutive days, researchers documented a 13% increase in neural tube defects among births conceived during that period, an estimated 6 additional cases (7). This is why pregnant people are advised against saunas: core body temperature above 39°C (102°F) is associated with higher risk of congenital anomalies.

Who Is Most at Risk

The populations most vulnerable to heat in pregnancy are those with the least ability to avoid it. Many pregnant people work in hot, humid environments performing physically demanding labor: agricultural work, factory work, jobs without adequate cooling. Some continue working in extreme heat late into pregnancy because they cannot afford to lose income. Workers may lack access to water or sanitation facilities, compounding dehydration risk.

People with pre-existing conditions including diabetes, cardiovascular disease, and mental illness face heightened risk. Low-income communities with limited access to air conditioning are disproportionately affected. This is not just a clinical issue. It is a health equity issue.

The rest of this post is for paid subscribers. Below you will find extensive resources how to protect yourself and what to do to prevent problems.

Subscribe now

Read more

When a patient walks into an obstetric practice, she assumes she is entering a medical relationship. Physician, patient, shared decision-making. But in a growing number of American communities, the entity making the most consequential decisions about that practice is neither the physician nor the patient. It is an investment firm.

Private equity ownership of physician practices has accelerated over the past decade. The pattern is consistent across specialties: an investment firm acquires a platform practice, consolidates smaller practices under it, standardizes operations, and positions the combined entity for resale at a profit, typically within three to seven years.

In obstetrics and gynecology, this model has specific implications.

Subscribe now

The Consolidation Pattern

Between 1998 and 2021, nearly 1,600 hospital mergers occurred in the United States. Rural hospitals acquired by larger systems are 30% less likely to still offer labor and delivery services five years after the merger. The closures disproportionately affect communities with lower incomes, higher Medicaid dependence, and fewer alternative providers.

Since 2020, 124 rural hospitals have stopped delivering babies or announced plans to stop, a 12% reduction in rural labor and delivery units. Less than half, just 41%, of U.S. rural hospitals still offer labor and delivery services. In 12 states, fewer than one-third do.

The pattern is not limited to rural areas. States like Rhode Island, Hawaii, and Oklahoma have seen up to 28% of urban hospitals close their obstetric units.

Why Obstetrics Is Vulnerable

Obstetric units are expensive to maintain. They require 24/7 staffing: obstetricians, anesthesiologists, nurses trained in labor and delivery, and the capacity for emergency cesarean sections. When birth volume is low, the cost per delivery rises. Malpractice premiums in obstetrics are among the highest in medicine.

For a hospital system optimizing financial performance, an obstetric unit with low volume and high fixed costs is a natural target. Closing the unit frees resources that can be directed toward more profitable service lines. The decision is financially rational.

It is also consequential. When an obstetric unit closes, families do not stop having babies. They travel farther, arrive later, and access fewer services. The number of births in a county does not change after a closure. The families just have to go elsewhere for care.

Fertility Medicine: The Investor’s Ideal

Fertility medicine has attracted particular investor interest for reasons described in Part 1 of this series. Much of the care is self-pay. Treatments recur over multiple cycles. Revenue can be expanded through laboratory services, genetic testing, and embryo storage. Pricing is less constrained by insurers than in most medical fields.

The result is a specialty where the most lucrative services are increasingly concentrated in investor-owned systems, while the least lucrative services, those that depend on Medicaid reimbursement, are the first to be cut. This is not a conspiracy. It is a market operating as markets do.

What Patients Don’t Know

Most patients do not know who owns the practice they visit. Ownership structures are rarely disclosed. A clinic may carry the name of its founding physician group long after that group sold to an investment platform. The patient sees the same logo, the same office, sometimes the same physician. The capital structure behind the practice is invisible.

Yet that capital structure determines which services are offered, which insurance is accepted, how many patients are seen per day, and what happens when the practice is sold again.

Transparency in health care ownership is not a radical idea. It is a basic condition for informed consent. A patient choosing a provider deserves to know whether that provider’s practice is owned by the physicians in it, by a hospital system, or by a private equity firm with a defined exit timeline.

The Ethical Shift

The traditional model of medical ethics centers on the physician-patient relationship. But when ownership is separated from clinical practice, the ethical framework must expand. Questions of access, continuity, and service availability are no longer solely clinical decisions. They are business decisions made by entities with no direct patient relationship and no professional obligation to the communities they serve.

The question for American obstetrics is whether the communities that need care the most will continue to be the ones where care is least profitable to provide.

The Ritual

Somewhere in the United States right now, a pregnant woman is being handed a form. It asks whether she has enough food to eat. Whether she has stable housing. Whether she feels safe at home.

She answers the questions.

A medical assistant enters her responses into the electronic health record.

A clinician glances at the results, adds a note, and generates a referral to a social worker who may or may not have an opening this month.

The appointment ends.

The woman goes home to the same food insecurity, the same unstable housing, the same unsafe situation that she described on the form.

Nothing changed. But the chart is complete. The quality metric is satisfied. The box is checked.

This is performative medicine.

It looks like care.

It generates documentation that looks like care. It satisfies regulators who measure care by whether the question was asked, not by whether the answer produced any result. And it has become one of the defining rituals of modern obstetrics, applied most aggressively to the most vulnerable women in the system, the women whose problems are the largest, and whose access to solutions is the smallest.

Asking a woman whether she is hungry and then doing nothing about it is not compassionate medicine. It is data collection dressed up as a clinical encounter.

What Social Determinants of Health Actually Are

The term social determinants of health, abbreviated SDoH in the medical literature and on the quality metric dashboards of health systems across the country, refers to the non-medical conditions that shape health outcomes. Where a person lives. Whether she has reliable transportation. Her income and employment status. Her level of education. Whether her neighborhood is safe. Whether she has a social support network.

These factors are not peripheral to health.

They are central to it.

The evidence on this is clear and has been clear for decades. Poverty is a more powerful predictor of maternal mortality than almost any clinical variable we measure.

A woman’s zip code predicts her obstetric outcomes with more accuracy than her blood pressure or her BMI. Black women in the United States die in childbirth at approximately three times the rate of white women, a disparity that persists across income and education levels, that survives adjustment for clinical risk factors, and that reflects the accumulated weight of structural disadvantage that no prenatal vitamin and no screening tool will touch.

This is not a new insight. What is new is the medical profession’s response to it: the creation of a screening infrastructure that identifies social determinants of health systematically, documents them carefully, and then largely fails to address them in any meaningful way.

The Screening Industry

The push to screen for social determinants of health in clinical settings accelerated dramatically after the Affordable Care Act tied hospital reimbursement to quality metrics that included social risk factor documentation. Health systems across the country adopted validated screening tools: the PRAPARE protocol, the Accountable Health Communities Health-Related Social Needs Screening Tool, the Hunger Vital Sign. These are not bad instruments. They identify real problems with reasonable accuracy. The question has never been whether the screening tools work. The question is what happens after they do.

The United States Preventive Services Task Force has grappled openly with this tension. When it evaluated screening for food insecurity in clinical settings, it noted that the evidence for screening benefit was limited by the scarcity of interventions that could follow a positive result.

The same logic applies across the SDoH spectrum. Screening is easy. Solutions are hard. The medical profession has invested heavily in the former while largely deferring the latter to social service systems that are chronically underfunded, fragmented, and inaccessible to the patients most in need.

The USPSTF’s implicit framework for evaluating screening is whether a positive result leads to an effective intervention. For most social determinants of health, that intervention does not exist in most communities. The screening logic collapses.

Why Obstetrics Is Especially Vulnerable to This Failure

Obstetrics attracts more mandatory screening requirements than almost any other clinical specialty. The prenatal visit is a regulatory and quality metric magnet. Screens for depression. Screens for intimate partner violence. Screens for substance use. Screens for food insecurity. Screens for housing instability. Each added in response to a real problem, each backed by an argument that identification is the first step toward intervention.

The prenatal visit also runs under ten minutes of face-to-face time. A clinician moving through the required documentation has approximately 90 seconds to administer a screening tool, process the result, counsel the patient, place a referral if indicated, and document all of it before the next patient is already waiting. This is not a clinical encounter. It is a triage assembly line that has been retrofitted with a social work function it was never designed to perform.

The burden of this system falls hardest on the patients it is supposed to serve. High-risk women, women with Medicaid coverage, women at safety-net hospitals, women in rural areas with limited specialist access, these are the patients who screen positive most often and have the least access to the resources that would make a positive screen meaningful. They are asked the questions most frequently. They benefit from the answers least.

The table above is not a critique of the clinicians who complete these screens or the social workers who receive the referrals. It is a description of a structural mismatch that no amount of clinical effort will resolve. The problems identified by SDoH screening are not medical problems that have been overlooked. They are social and economic problems that have been handed to the medical system because no other system has been adequately funded to address them.

The Moral Hazard of Performative Medicine

There is a concept in economics called moral hazard: when a system creates the appearance of managing a risk, it can reduce the pressure to address that risk at its source. Performative medicine operates through a similar mechanism. When health systems can document that they screened for food insecurity, when quality dashboards show high rates of SDoH assessment, when accreditation bodies award credit for the process of screening, the urgency to address the underlying structural failures diminishes.

The clinician who asks a patient whether she has enough food and documents the answer has discharged her professional obligation as defined by the quality metric. She has not fed the patient. She has not changed the conditions that produced the food insecurity. She has, in a real sense, transferred the problem from the patient to the chart, where it will sit, documented and unresolved, until the next visit when it will be screened for again.

This is not a cynical observation about clinicians. Most of the physicians, midwives, and nurses who administer these screens do so with genuine concern for their patients. The cynicism is structural. A system that rewards documentation of a problem, rather than resolution of it, is a system that has organized itself around the performance of care rather than its substance.

When the metric is whether you asked the question, and not whether you changed the answer, you have built a machine for generating paperwork, not improving health.

The Institutional Benefit of the Status Quo

Health systems benefit from SDoH screening in ways that have nothing to do with patient outcomes. High rates of positive SDoH screens support claims of serving a high-risk population, which can influence reimbursement rates and justify additional resources. Documentation of social risk factors can serve as explanatory variables when outcomes are poor, providing institutional cover for mortality and complication rates that might otherwise invite scrutiny. Screening also generates data, and data has value in grant applications, research publications, and marketing materials about commitment to health equity.

None of this means SDoH screening serves no purpose. Identification can matter when interventions exist. But the current system has inverted the logical order: it screens first, systematically and at scale, and then treats the absence of solutions as a downstream problem for someone else to solve.

What Actually Moves Maternal Outcomes

The evidence on what improves obstetric outcomes is not ambiguous. It points consistently in a direction that has nothing to do with screening forms and everything to do with access, coverage, and quality of care.

Insurance That Actually Covers Care

Women with comprehensive insurance coverage have measurably better obstetric outcomes than women with limited coverage or no coverage. This is not a subtle effect. It operates across every outcome we measure: maternal mortality, severe maternal morbidity, preterm birth, low birth weight, postpartum complications. The gap between Medicaid coverage and private insurance in obstetric outcomes is real, persistent, and documented across multiple large datasets.

A woman who cannot afford her antihypertensive medication does not need a food insecurity screen. She needs a formulary that covers her medication without a copay she cannot pay.

Freedom to Choose a Skilled Clinician

The physician-patient relationship in obstetrics is not interchangeable. Outcomes vary across individual clinicians within the same institution. Continuity of care, seeing the same clinician across the prenatal period, is associated with better outcomes, higher patient satisfaction, and better identification of clinical risk.

A system that routes low-income women to whoever is available, across fragmented safety-net systems where continuity is nearly impossible to achieve, is a system that has decided that care quality is a function of what you can pay for. Screening those women for social determinants of health does not change that calculus.

Access to High-Quality Hospitals

Where a woman delivers matters enormously. High-volume centers with dedicated maternal-fetal medicine units, robust nursing ratios, and 24-hour anesthesia coverage have better maternal outcomes than low-volume community hospitals.

The geography of hospital quality in the United States maps almost perfectly onto the geography of income and race. Low-income women and Black women are more likely to deliver at hospitals with higher complication rates, not because of their clinical risk profiles, but because of where they live and what their insurance will cover. No screening tool changes which hospital a woman can access.

What Honest Medicine Looks Like

I am not arguing that clinicians should stop asking their patients about their lives. Context matters, as I have written before, and the clinician who understands a patient’s circumstances will always deliver better care than one who does not. The difference between contextual medicine and performative screening is the intent and the consequence.

Contextual medicine means asking about a patient’s life because the answer will change what you do in that visit. It means finding out that she stopped taking her medication because she cannot afford it, and changing the prescription. It means discovering that she does not have transportation, and calling in the prescription to a pharmacy near her home instead of one near the clinic. It means learning that she is not safe at home, and spending the rest of that visit, and the next one, making a safety plan that is specific to her situation.

Performative screening means asking the same questions because the quality metric requires it, documenting the answers because the electronic health record prompts the documentation, and generating a referral because the protocol specifies a referral, whether or not anyone in that patient’s community can act on it.

The distinction is not always visible from outside the encounter. Both produce documentation. Only one produces care.

Honest medicine requires us to say plainly what the evidence shows: if you want to improve maternal outcomes in the United States, the intervention is insurance, access, and quality of care. Not a questionnaire.

What Health Systems Should Stop Doing

Health systems should stop treating SDoH screening as a quality measure when the referral infrastructure does not exist to act on positive results. They should stop reporting high rates of SDoH screening to accreditation bodies as evidence of commitment to health equity when outcomes for the women who screen positive are unchanged. They should stop using SDoH documentation as an explanatory variable for poor outcomes without also accounting for what they did, or failed to do, with the information they collected.

What Health Systems Should Start Doing

Health systems that serve high-risk populations should invest in the infrastructure that makes a positive SDoH screen actionable: on-site or embedded social work with actual capacity, partnerships with food programs that can deliver, housing navigators with real relationships with local landlords and programs, legal services for patients with immigration concerns. These are expensive. They are also what the evidence says works. A screening program without this infrastructure is not a health equity initiative. It is a documentation program.

More fundamentally, the medical profession needs to be honest with policymakers, regulators, and the public about what medicine can and cannot do. Medicine can identify a woman who is food insecure. Medicine cannot feed her. Medicine can document that she lives in an unsafe neighborhood. Medicine cannot make it safe. Medicine can screen for intimate partner violence. Medicine cannot end it. The solutions to social determinants of health are social and political, not clinical. Pretending otherwise, by building screening programs that substitute for policy, is a disservice to the patients those programs claim to serve.

The Bottom Line

The United States spends more on maternity care per birth than any other high-income country and achieves outcomes that rank near the bottom of the same group. The maternal mortality rate is rising. Racial disparities in maternal outcomes are not closing. The response of the medical establishment to this failure has included, prominently, the expansion of social determinants of health screening in prenatal settings.

Screening is not the problem. The problem is a system that has adopted screening as a substitute for the structural changes that would actually matter: universal comprehensive coverage, payment models that support continuity and quality, equitable access to high-volume centers, and investment in the communities where the most vulnerable women live and give birth.

The woman who fills out a food insecurity screen at her prenatal visit deserves more than documentation of her hunger. She deserves a system that takes responsibility for what it finds. Until that system exists, the most honest thing we can say about SDoH screening in obstetrics is that we are very good at identifying problems we are not prepared to solve.

If the screen leads nowhere, the screen is not medicine. It is theater. And the audience paying the price is the patient.

The Due Date Is a Guess. Now There Is Something Better.

A pregnant woman sits across from me. She is 28 years old, healthy, first pregnancy. She asks the question every patient asks: “When will my baby come?”

For 50 years, I gave her some version of the same answer. I told her her due date. I told her labor could begin a few weeks before or after. I told her to watch for contractions. I sent her home.

What I did not tell her is that the due date is a 200-year-old formula based on a small, unrepresentative dataset, never validated in a randomized trial, and correct for fewer than 5 in 100 women. I did not tell her this because obstetrics, as a field, had not found anything better to offer.

That changed. But first, it is worth understanding what we have been using, and why.

Naegele’s Rule: A Formula Built on Assumptions

Franz Karl Naegele was a German obstetrician who published his method of calculating the estimated due date in 1830. His rule is simple: take the first day of the last menstrual period, add seven days, subtract three months, add one year.

The calculation assumes a 28-day menstrual cycle with ovulation on day 14. It assumes every woman is the same. It assumes the first day of the last period is known precisely. It assumes conception follows a predictable schedule. None of these assumptions are consistently true.

Naegele based his rule on observations reported by the Dutch physician Hermann Boerhaave from the early 1700s, who himself was working from a small number of cases. The formula entered obstetric practice not because it was validated but because it was simple and nothing else existed.

We have been using it ever since.

What the Evidence Actually Shows

The literature on gestational length is more unsettling than most clinicians acknowledge. A 2013 study published in Human Reproduction by Jukic et al. followed 125 women with precisely confirmed ovulation dates using daily urine samples and found that the duration of pregnancy varied by as much as 37 days among women with no identified risk factors. (1) Thirty-seven days. That is more than five weeks of natural variation in a population most physicians would call low-risk.

Naegele’s rule does not account for one day of this variation.

Further research has confirmed that cycle length matters enormously. Women with cycles longer than 28 days carry longer. Women who conceive later in their cycle carry longer. Parity matters: first-time mothers tend to deliver about 2 to 3 days later than women who have delivered before. (2) Race matters: Black women in the United States tend to deliver earlier on average, a difference that the due date formula ignores entirely.

And yet the single number on the prenatal chart is still calculated the same way Naegele calculated it in 1830.

What Patients and Families Actually Want to Know

When a pregnant woman asks “when will my baby come,” she is not asking for a formula. She is asking for a picture. She wants to know: is it this week? The week after? Should I have my bag packed? Is my mother-in-law’s flight from Munich too early?

The due date does not answer any of those questions. It gives a single day that is almost certainly wrong and no information about the days surrounding it.

What patients want, and what the evidence supports, is a probability distribution. Not a point estimate. A picture of when, specifically, labor is most likely to begin for this woman, given what we know about her.

When is she most likely to go into labor? What is the probability labor begins before 37 weeks? What is the probability she still has not delivered by 41 weeks? These are answerable questions. The due date does not answer them. A calibrated probability tool can.

Families plan around these numbers. Childcare arrangements, birth partners’ travel schedules, work leave timing, decisions about induction: all of these are shaped by the due date. Giving families a single date with no context is not just imprecise. It is a missed opportunity to give them something genuinely useful.

After 200 Years: Something Better

200 years after naegele and after 50 years of telling patients “you are due around your due date,” I finally built something better.

The Labor Probability Calculator generates a personalized, day-by-day chart showing when spontaneous labor is most likely to begin, starting from today. Not a due date. Not a range. A probability curve.

It adjusts for cervical length, dilation, effacement, BMI, parity, prior preterm or post-term history, twin gestation, and maternal age. Fourteen peer-reviewed sources went into the model. Every number is traceable.

The technical problem I had to solve is one that most due date tools get wrong. A standard bell curve places the peak probability at 40 weeks exactly and distributes risk symmetrically. But that is not how birth works. The distribution is skewed. Preterm birth is more common than most people think, and the tail of the distribution extends further past 40 weeks than a symmetric model predicts.

Most online tools predict fewer than 3 percent of births occurring before 37 weeks. The actual number, from national birth data, is 9 to 10 percent. (3) A symmetric bell curve is not a model of reality. It is a mathematically convenient fiction.

The Labor Probability Calculator uses a skewed distribution that reflects what actually happens, not what a symmetric curve wishes would happen.

Who This Is For

This tool is for two audiences.

For clinicians, it is a counseling aid. When you are discussing induction timing with a patient, you now have something to show her: a personalized chart of when labor is likely to begin on its own. The conversation about induction becomes a conversation about probability, not a negotiation about dates.

For patients and families, it is an answer to the question the due date never answered. Not a prediction. A probability. Specific to you, based on what your clinician knows about your pregnancy today.

It is the most evidence-based labor prediction tool available online. Fourteen peer-reviewed sources. Absolute probabilities, not vague ranges. A skewed distribution that matches observed birth data.

Try the Labor Probability Calculator: liveevidence.com/tools/labor-probability

My Take

Naegele’s rule is not wrong because Franz Karl Naegele was a bad physician. He was working in 1830 with the tools of 1830. The problem is that obstetrics adopted his formula and then largely stopped asking whether it was still the best we could do.

The answer is that it is not.

We have better data.

We have better computing.

We have 14 peer-reviewed studies on the factors that shape gestational length.

We have the capacity to give patients a probability curve instead of a single date.

We also have an ethical obligation to give patients information that is actually accurate. Telling a woman she is due on a specific date when the evidence shows a range of five or more weeks of natural variation is not reassuring. It is imprecise. And imprecision, in obstetrics, has consequences.

The due date will not disappear from the chart. It is too embedded in coding systems, reimbursement structures, and clinical workflows. But it should stop being the only number we give patients. It should stop being treated as a prediction when it was never designed to be one.

We can do better. We have built something better. Use it.

References

1. Jukic AM, Baird DD, Weinberg CR, McConnaughey DR, Wilcox AJ. Length of human pregnancy and contributors to its natural variation. Hum Reprod. 2013;28(10):2848-2855.

2. Mittendorf R, Williams MA, Berkey CS, Cotter PF. The length of uncomplicated human gestation. Obstet Gynecol. 1990;75(6):929-932.

3. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2022. Natl Vital Stat Rep. 2023;72(13):1-51. [VERIFY: confirm exact preterm birth rate figure from most recent natality data]

Not all hospitals are the same. This is obvious in theory. It is consequential in practice.

In American obstetrics, which hospital a woman delivers in is one of the strongest modifiable predictors of whether she and her baby will be harmed.

The research is clear: Black women deliver in a concentrated set of hospitals, and those hospitals have higher rates of severe maternal morbidity for both Black and white patients. The problem is not only who the patient is. It is where she delivers.

This is not true in Europe where all hospitals accept all patients and where maternal and neonatal outcomes are many many times better.

The Concentration Problem

A landmark study using the Nationwide Inpatient Sample found that just one quarter of U.S. hospitals provide care for three quarters of all Black deliveries. These are not randomly distributed hospitals. They are a defined set of institutions, identifiable and measurable.

Researchers ranked hospitals by the proportion of their deliveries to Black patients. High Black-serving hospitals, those in the top 5%, had severe maternal morbidity rates of 29.4 per 1,000 deliveries. Low Black-serving hospitals had rates of 12.2 per 1,000. After adjusting for patient characteristics, comorbidities, and hospital factors, the difference narrowed but remained significant: 17.3 versus 13.5 per 1,000.

This is not a story about patient risk alone. White women who delivered at high Black-serving hospitals also had worse outcomes than white women at other hospitals. The hospital itself contributes to the risk.

Quality Varies. Distribution Does Not.

Obstetric quality varies enormously across American hospitals. Rates of severe maternal morbidity vary four to fivefold between institutions. Neonatal complication rates vary sevenfold. Cesarean section rates for low-risk first births range from under 15% at some hospitals to over 40% at others.

If this variation were random, patient demographics would not predict which end of the quality spectrum a woman experiences. But it is not random.

A study of 40 New York City hospitals found that one in three Black and Hispanic women delivered at a hospital in the highest neonatal morbidity category. One in ten white and Asian American women did. These are low-risk, term, singleton births with normal birth weight. The difference in outcome is not explained by the patients. It is explained by where they deliver.

Black-serving hospitals performed worse on 12 of 15 delivery-related quality indicators in a seven-state analysis. Within those hospitals, there were few differences in outcomes between racial groups, suggesting that the overall quality of the institution, not differential treatment within it, drives much of the disparity.

Why the Hospitals Are Different

High Black-serving hospitals are not worse because they serve Black patients. They are worse because of the structural conditions under which they operate.

These hospitals serve populations with higher rates of Medicaid coverage. As this series has documented, Medicaid reimburses at roughly 40 to 45 cents on the dollar compared to commercial insurance. Hospitals with high Medicaid payer mixes have less revenue per patient, thinner operating margins, and fewer resources to invest in staffing, equipment, and quality improvement programs.

They are more likely to be located in under-resourced communities with higher poverty rates, fewer primary care providers, and less robust public health infrastructure. Their patients arrive with more unmanaged chronic disease, less consistent prenatal care, and more social stressors, not because of personal failure but because the systems upstream have already failed them.

These hospitals often have higher nurse-to-patient ratios, less subspecialty coverage, fewer simulation training programs, and older physical infrastructure. They are less likely to have implemented standardized safety bundles for hemorrhage, hypertension, and venous thromboembolism. None of this is invisible. All of it is measurable.

Within-Hospital Disparities

Hospital quality explains part of the racial disparity in obstetric outcomes. It does not explain all of it.

Even within the same hospital, Black women experience higher rates of severe maternal morbidity than white women. After adjusting for medical risk factors, the gap narrows but does not disappear. This within-hospital disparity points to differences in how care is delivered to different patients in the same institution: how quickly symptoms are recognized, how aggressively complications are managed, how seriously patient concerns are taken.

Studies have documented that Black women’s reports of pain are more likely to be minimized. Their vital sign abnormalities are more likely to be observed rather than acted upon. Their concerns are more often attributed to anxiety rather than to a clinical problem that warrants investigation.

These are not fringe findings. They are consistent across multiple studies, multiple institutions, and multiple outcomes. The between-hospital and within-hospital effects are additive. A Black woman delivering at a high Black-serving hospital faces both a lower-quality institution and a higher likelihood of differential treatment within it.

The Modifiable Factor

Hospital quality is one of the few modifiable factors in the maternal morbidity equation. Social determinants of health, neighborhood conditions, chronic disease burden, and poverty are real contributors to adverse outcomes, but they are difficult to change at the point of care. Hospital quality can be changed at the point of care.

Safety bundles work. The California Maternal Quality Care Collaborative demonstrated that standardized protocols for hemorrhage, hypertension, and venous thromboembolism reduce maternal morbidity. When these protocols are implemented at hospitals with high morbidity rates, outcomes improve for all patients.

Disparities dashboards work. When hospitals stratify their quality metrics by race and ethnicity, disparities that were invisible in aggregate data become visible and actionable. You cannot fix what you do not measure. You cannot measure what you do not stratify.

Targeted investment works. Directing quality improvement resources to the hospitals where outcomes are worst, rather than distributing them evenly, produces the largest gains. Since Black women deliver in a concentrated set of hospitals, improving care at those hospitals disproportionately benefits the population with the highest risk.

The Choice We Are Making

The concentration of Black deliveries in lower-quality hospitals is not a natural phenomenon. It is the downstream result of the structural forces described throughout this series: insurance-driven access patterns, geographic segregation, Medicaid reimbursement gaps, and ownership decisions that determine which hospitals maintain and which hospitals close obstetric services.

We know which hospitals have the worst outcomes. We know which populations they serve. We know what interventions improve quality. The question is not whether the problem is identifiable. It is whether we treat hospital quality as a matter of equity or continue to treat it as a matter of individual patient risk.

When the same hospital produces worse outcomes for all its patients, the problem is not the patient. It is the hospital. And when we know which hospitals those are and do nothing, the problem is us.

Forty-two percent. That is the share of American births covered by Medicaid. Among Black mothers, the number is 64%. Among Hispanic mothers, 58%. Medicaid is the single largest payer of maternity care in the United States.

And yet, across the country, the gap between Medicaid coverage and Medicaid access is widening.

Coverage means a card in your wallet. Access means a physician who will see you. These are not the same thing.

Who Accepts, Who Doesn’t

Nationally, about 82% of obstetrician-gynecologists accept new Medicaid patients. That sounds adequate until you look more closely. Among subspecialists, particularly maternal-fetal medicine specialists, reproductive endocrinologists, and gynecologic oncologists, the acceptance rates are lower, often much lower.

In states that expanded Medicaid under the Affordable Care Act, ObGyn acceptance actually dropped to 74%, compared to 90% in non-expansion states, likely because expansion increased demand without a proportional increase in reimbursement.

The math is straightforward. Medicaid pays roughly $6,500 for a delivery. Employer-sponsored insurance pays about $7-15,000. A practice that shifts its payer mix toward Medicaid without increasing volume faces a direct reduction in revenue per patient. Practices respond rationally. They limit Medicaid slots, restrict scheduling windows, or stop accepting new Medicaid patients altogether.

None of this requires anyone to be biased. The wall is built from reimbursement spreadsheets, not from prejudice.

The Geography of Exclusion

The Medicaid wall is not uniform. It varies by state, by specialty, and by region. In states with the lowest Medicaid-to-Medicare fee ratios, access is worst. Patients in these states face longer wait times, fewer available providers, and greater distances to reach subspecialty care.

More than a third of U.S. counties have no obstetrician and no birthing center. The March of Dimes reports that 2.2 million women of childbearing age live in maternity care deserts. These deserts overlap heavily with communities where Medicaid is the dominant insurer.

This is not a coincidence. When reimbursement is low and volume is limited, practices close or consolidate. The communities most dependent on Medicaid are the ones most likely to lose services.

What the Medicaid Wall Costs

The consequences of the Medicaid wall are measurable. Women in maternity care deserts travel an average of 2.6 times farther to reach a hospital with labor and delivery services. Longer travel times during labor are associated with higher rates of out-of-hospital births, delayed care for complications, and longer hospital stays.

Medicaid patients are less likely to receive early prenatal care, less likely to access subspecialty referrals, and less likely to have continuity of care across pregnancy and postpartum. These are not failures of patient motivation. They are failures of system architecture.

The Medicaid wall does not announce itself. There is no sign on the door that says poor women not welcome. The wall is built from policies that look neutral: network restrictions, scheduling algorithms, panel caps, credentialing delays. Each one is defensible in isolation. Together, they create a barrier that is predictable in who it excludes.

The Professional Responsibility Question

Medicine has historically understood Medicaid acceptance as a professional obligation. ACOG states that Medicaid is essential to ensuring healthy mothers and babies. The American Medical Association’s principles of medical ethics include a responsibility to support access to care for all patients.

But professional principles do not pay overhead. The tension between professional obligation and financial viability is real. The question is not whether the tension exists. It is whether we acknowledge it honestly or pretend it does not shape who gets care.

A system that covers 42% of births but cannot guarantee those births access to adequate care is not a coverage system. It is a coverage illusion.